Nonprofit, nonpartisan journalism. Supported by readers.



How not to fall for stem cell hype

“We remain very concerned that countless clinics across the country continue to market violative stem cell products to patients that have not been appropriately evaluated for safety or efficacy,” said Dr. Peter Marks of the FDA.